The US FDA is launching another public shaming campaign aimed at discouraging anti-generic regulatory tactics – this one to root out gaming of the citizen petition process – but it may prove more effective at conserving agency resources than curtailing abuse.
The agency's responses to citizen petitions may now state whether FDA believes they were submitted simply as a delaying tactic,...







